Vaxcyte's total assets for Q1 2025 were $3.38B, a decrease of -3.79% from the previous quarter. PCVX total liabilities were $178.08M for the fiscal quarter, a -13.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.